Navigation Links
New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma

- Positive data on subcutaneous administration show potential for new option to improve convenience for patients -

CHICAGO, June 04, 2007 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. today announced the presentation of positive data for VELCADE, the market-leading therapy for patients with multiple myeloma (MM) who have received at least one prior therapy. These data include results from a Phase II trial for subcutaneous (SC) administration of VELCADE, a new option under evaluation. Results were also presented from the international Phase III trial of VELCADE + DOXIL, which served as the basis for the recent U.S. approval of the combination and showed significant improvement in time to disease progression compared to VELCADE alone, the current standard of care. The VELCADE + DOXIL abstract was selected by the Best of the American Society of Clinical Oncology (ASCO) Program Committee as one of the premier abstracts at the 43rd Annual Meeting in Chicago.

"We and our partner Johnson & Johnson Pharmaceutical Research and Development L.L.C. continue to develop new clinical data that reinforce the role of VELCADE as the U.S. market-leading therapy in previously treated multiple myeloma," said Nancy Simonian, M.D., Chief Medical Officer, Millennium. "These data demonstrate that VELCADE in combination with another active agent can further strengthen the unparalleled impact of VELCADE. We are aggressively pursuing development of a subcutaneous delivery form to broaden alternatives for patients who prefer to receive VELCADE treatment at home."

Prospective Comparison of Subcutaneous to Intravenous Administration of Bortezomib in Patients with Multiple Myeloma: Pharmacokinetics, Efficacy and Toxicity (Abstract #8046)

This randomized trial evaluated the pharmacokinetics/pharmacodynamics (PK/PD), toxicity and response rate of VELCADE in patients treated with either an SC or intravenous
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
3. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
4. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
5. Study Shows Velcade Plus Doxil Improves Survival in Previously Treated Patients With Multiple Myeloma
6. Millennium Discovers Biomarkers Potentially Predictive of Response to Velcade (Bortezomib) for Injection
7. Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer Patients Treated with Therapy Based on Ratiometric Dosing
8. Palatin Technologies and King Pharmaceuticals Report Data Showing Improvements in Sexual Relationship and Self-Esteem in Patients with Erectile Dysfunction Treated with Bremelanotide
9. Pegasys Study Authors Conclude that Patients Successfully Treated for Hepatitis C Can be Considered Cured
10. Study Continues to Show Patients With Myelodysplastic Syndromes Treated With Revlimid are Living Longer and Remaining Transfusion Independent
11. Preterm Infants with Respiratory Distress Syndrome: Incidence Rates of Death when Treated with Surfactant Replacement Therapies
Post Your Comments:
(Date:10/31/2014)... YORK , October 31, 2014 ... Celgene Corporation (NASDAQ: CELG ), Bristol-Myers Squibb ... (NYSE: UNH ), Sanofi SA (NYSE: ... wealth members receive these notes ahead of publication. To ... http://www.analystsreview.com/7593-100free . , ,-- ,Celgene Corporation Research Reports ,On ...
(Date:10/31/2014)... 2014  Encision Inc. (OTCQB:ECIA), a medical device company ... burns in minimally invasive surgery, today announced financial results ... 2014. The Company posted quarterly net revenue ... $414 thousand, or $(0.04) per share. These results compare ... loss of $50 thousand, or $(0.01) per share, in ...
(Date:10/31/2014)... , Oct. 30, 2014 ... the electronic transmission of prescription related information ... E-Prescribing system allows a physician and nurse ... when a medication error occurs during pharmacy ... of applications. It provides complete medical lists, ...
Breaking Medicine Technology:Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 2Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 3Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 4Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 5Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 6Encision Reports Second Quarter Fiscal Year 2015 Results 2Encision Reports Second Quarter Fiscal Year 2015 Results 3Encision Reports Second Quarter Fiscal Year 2015 Results 4Encision Reports Second Quarter Fiscal Year 2015 Results 5E-Prescribing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2
... Therapy Services Holdings, Inc. ("Radiation Therapy Services" or the "Company") ... Wells Fargo Securities 2011 Healthcare Conference on Wednesday, June 22, ... held at the Intercontinental Hotel in Boston, MA. ... available by visiting the Events section of the Company,s Web ...
... ERT ), announced today that Keith ... present at the 2011 Wells Fargo Securities Healthcare ... in Boston. Interested parties may access ... at  http://www.ert.com . The webcast may also be ...
Cached Medicine Technology:ERT to Present at the 2011 Wells Fargo Securities Healthcare Conference on June 23, 2011 2
(Date:10/31/2014)... 2014 Activz Whole-Food Nutrition ... line offering natural silver healing support† in liquid ... century, silver has been used to support natural healing, ... is the most advanced version available. This latest formula, ... structure that supports the existing healing mechanisms in the ...
(Date:10/31/2014)... 2014 (HealthDay News) -- Sleep apnea may make it hard ... parked your car or left your house keys, a small ... apnea showed that this ability -- called spatial memory -- ... sleep, even when other stages of sleep weren,t affected. REM ... typically occur. "We,ve shown for the first time that ...
(Date:10/31/2014)... IL – New research suggests that insomnia is a ... and other unintentional fatal injuries. The results underscore the ... the National Healthy Sleep Awareness Project. , Results show ... a dose-dependent manner with the number of insomnia symptoms ... 2.8 times more likely to die from a fatal ...
(Date:10/31/2014)... Barbara, CA (PRWEB) October 31, 2014 ... holiday shoppers to find affordable but tasteful gifts for the ... 22nd Annual Early Bird Gift Giving Special , which ... off when they purchase Wine Club Gift membership. , ... take advantage of this special. Besides offering discounts, Gold Medal ...
(Date:10/31/2014)... 31, 2014 Urban Hydroponics, Inc. (OTCQB:URHY), ... announced it has signed a Binding Letter of Intent ... urban cultivation sector - Urban Cultivator Inc. (“Urban Cultivator”), ... W3 Metal Inc. (“W3 Metal” and together with Urban ... Pursuant to the LOI and an earlier non-binding term ...
Breaking Medicine News(10 mins):Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 2Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 4Health News:Sleep Apnea May Steal Some of Your Memory: Study 2Health News:Insomnia increases risk of motor vehicle deaths, other fatal injuries 2Health News:Gold Medal Wine Club now offering Early Bird Gift Giving Special for Holidays 2Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 2Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 3Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 4Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 5
... 11 , - With Photo , ... three ,mini, entrepreneurs today went,head-to-head to win a GBP2,000 investment from ... school children faced their toughest,challenge yet when they presented their big ... Shannon Stokes, 9, from Neith, South Wales, ...
... of healthcare employment Web sites offers recruitment and career opportunities to ... ... the midst of a slowing economy and as unemployment climbs, many ... ,"Healthcare continued to add jobs in February, with a gain of ...
... Records Critical to Improving Quality of U.S. HealthcarePLANO, Texas, ... PER ), the U.S. market leader for providing healthcare ... host a second comprehensive webinar about the impact that ... will have on the U.S. Healthcare industry. The ...
... March 11 The National Alliance on Mental Illness (NAMI) ... the state of mental health care in our state. ... D grade - a decline in its rating . Fourteen ... back including Michigan. "We are disappointed that Michigan,s mental health ...
... -- One in seven American adolescents is vitamin D deficient, ... of Public Health at Weill Cornell Medical College. The findings ... Pediatrics and were presented at the Pediatric Academic Societies, ... deficiency can interfere with bone mineralization, leading to rickets. In ...
... Truck crashes are a significant public health hazard ... with driver fatigue and sleepiness being major causes. ... obesity-driven testing strategies identify commercial truck drivers with ... and suggests that mandating OSA screenings could reduce ...
Cached Medicine News:Health News:"I'm In" - Duncan Bannatyne Judges "Switch Ash for Cash" Schools Competition 2Health News:"I'm In" - Duncan Bannatyne Judges "Switch Ash for Cash" Schools Competition 3Health News:"I'm In" - Duncan Bannatyne Judges "Switch Ash for Cash" Schools Competition 4Health News:Healthcare Industry Continues to Post Gains in a Down Economy 2Health News:Perot Systems Launches Webinar Series and Website Resources on Healthcare Stimulus Plan Provisions 2Health News:Perot Systems Launches Webinar Series and Website Resources on Healthcare Stimulus Plan Provisions 3Health News:Michigan's Mental Health Care System Gets a D Grade in Latest Study 2Health News:One in seven US teens is vitamin D deficient 2Health News:Obesity linked to dangerous sleep apnea in truck drivers 2Health News:Obesity linked to dangerous sleep apnea in truck drivers 3
Spectrafuge 24D High speed, digital microcentrifuge. Precision control with digital display. Easy access 24-place rotor. Set and view speed in rpm or rcf. Quiet and cool running. StripSpin adapter fo...
... More Separating Power , Micromax produces forces up ... on 24 (1.5-2.0 mL) samples or 48 (0.5 ... brushless motor is designed for longevity and requires ... money. In addition, all controls are microprocessor based ...
... two centrifuges -- the world's most popular ... in one reliable, quiet, compact unit. It ... two separate centrifuges!, For your microcentrifuge needs, ... supplies you with the MicroMB centrifuge, microcentrifuge ...
... The Centrifuge 4-15C is designed to accommodate the ... the necessary force of more than 5600 x ... wide range of both fixed-angle and swing-out rotors ... 5 ml, 15 ml, and 50 ml tubes, ...
Medicine Products: